跳至主要内容
临床试验/CTRI/2025/07/090956
CTRI/2025/07/090956尚未招募不适用

Evaluation of Clinical efficacy of Khadira Saaradi churna Oral And Edagajadi Lepa External in the management of Vicharchika wsr To Eczema

Dr Chevuri Spandana1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年7月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To reduce the Itching of Eczema

研究概览

简要总结

Ayurveda has given prime importance to skin disorders since ancient times

A Wide range of Skin Diseases are included under KUSTA Which is further classified as Mahakustas and Kshudrakustas

Vicharchika is one among the Kshudra kustas which is tridoshaja vyadhis having classical signs and symptoms of KANDU because of Kapha  SRAVA due to Pitta dominance and SHYAVA VARNA due to dominance of Vata

As per Modern Medicine VICHARCHIKA  analogous with Eczema

Ayurveda describes a multitude of treatment modalities for skin diseases One of them being topical use of medicaments over the skin which allows faster absorption and better treatment of skin diseases

Even though there are many medications to combat the disease vicharchika it is the quality that matters

Hence the study has been initiated to findout simple economic and effective medicament for Vicharchika

In the present context an attempt has been made to bring out an effective management for the disease VICHARCHIKA by using herbo-mineral compound KHADIRASAARADI CHURNA for Oral Administration is having Rasayana Tridoshahara Anulomana Mehahara properties and EDAGAJADI LEPA for external use is having Lekhana Kustagna Kandughna Rasayana properties

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients of either gender with the age group between
  • 60 years Classical Signs and Symptoms of Vicharchika like Kandu Pidaka Shyavavarna Rukshatha and with or without Srava Recently diagnosed and with chronicity less than 3 years Patients suffering with controlled Diabetes mellitus Patients who has given consent for the study.

排除标准

  • Patients of either gender with the age group below 18 years and above 60 years Lactating mother and pregnant women Lesions with secondary infection Patients suffering with Uncontrolled Diabetes mellitus Uncontrolled Hypertension Malignancies AIDS TB And Other Systemic Disorders which interferes with the course of treatment.

结局指标

主要结局

To reduce the Itching of Eczema

时间窗: 45 Days

次要结局

  • To reduce the symptoms of disease vicharchika(45 Days)

研究者

发起方
Dr Chevuri Spandana
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Chevuri Spandana

Dr BRKR Government Ayurvedic College And Hospital

研究点 (1)

Loading locations...

相似试验